1. Yang R, Su YD, Ma R, Li Y*.Clinical epidemiology of peritoneal metastases in China: The construction of professional peritoneal metastases treatment centers based on the prevalence rate.Eur J Surg Oncol.2023.49(1).173-178.SCI |
2. 张颖, 李鑫宝, 林育林, 马茹, 徐大钊, 赵鑫, 闫风彩, 李雁.基于真实世界数据的腹膜假黏液瘤诊治现状分析.中国肿瘤临床.2022.49(5).217-223.核心期刊 |
3. 杜雪梅, 魏亚萍, 高颖, 卞雅霓, 张建梅, 李雁*.上皮样型恶性腹膜间皮瘤透明细胞亚型2例.中华病理学杂志.2022.51(1).68-70.核心期刊 |
4. Zhao X, Li X, Lin Y, Ma R, Zhang Y, Xu D, Li Y*.Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.Cancer Med.2022.12(3).2637-2645.SCI |
5. Su YD, Yang ZR, Li XB, Yu Y, Du XM, Li Y*.Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China.Int J Hyperthermia.2022.39(1).706-712.SCI |
6. Wu HL, Yang ZR, Su YD, Ma R, Du XM, Gao Y, Li Y*.Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases.World J Surg Oncol.2022.20(1).350.SCI |
7. Wu HL, Yang ZR, Yan LJ, Su YD, Ma R, Li Y*.NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine.World J Surg Oncol.2022.20(1).141.SCI |
8. 潘静涵, 李鑫宝, 姬忠贺, 刘刚, 李雁*.腹膜癌静脉血栓栓塞症高危患者围手术期预防护理.护理学杂志.2022.37(16).35-37.核心期刊 |
9. Yang ZR, Su YD, Ma R, Wu HL, Li Y*.Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study.Front Oncol.2022.12.811800.SCI |
10. 苏延冬, 刘刚, 杜雪梅, 李雁*.弥漫性恶性腹膜间皮瘤伴副肿瘤综合征1例报道及文献复习.肿瘤防治研究.2022.49(3).246-250. |
11. 安松林, 李鑫宝, 姬忠贺, 马玲, 孙志鹏, 李雁*.综合性医院肿瘤外科学科建设经验探讨.中国卫生人才.2022.000(004).56-59. |
12. 徐大钊, 林育林, 马茹, 李曌, 闫风彩, 赵鑫, 陈佳梅, 李雁*.Gsα蛋白与腹膜假黏液瘤临床病理特征及预后的相关性研究.中国肿瘤临床.2022.49(6).275-279.核心期刊 |
13. 姬忠贺, 安松林, 李雁*.腹膜癌研究历程及腹膜肿瘤学学科建设.中国肿瘤临床.2021.48(17).870-875. |
14. 李曌, 陈奕至, 孟巍, 杨智冉, 林育林, 张珏, 孙萍萍, 杜雪梅, 曲丛玲, 昌红, 韦继学, 李雁*.两种商业化二抗在免疫组织化学染色中一致性的比较.细胞与分子免疫学杂志.2021.37(1).47-53. |
15. 杨沛刚, 李鑫宝, 刘刚, 安松林, 李勇, 赵群, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜后巨大脂肪肉瘤.肿瘤防治杂志.2021.48(1).103-106. |
16. 崔力方, 昌红, 余春开, 陈奕至, 李雁*.细胞形态温和的乳腺原发梭形细胞病变的病理诊断分析.临床与实验病理学杂志.2021.37(5).574-578. |
17. 安松林, 张凯, 李雁*.腹膜癌患者术后发热处理的带教经验总结.继续医学教育.2021.35(1).47-49. |
18. 杜雪梅, 张程燕, 陈奕至, 昌红, 李雁*.临床病理科住院医师规范化培训教学查房模式探索.中国病案.2021.22(9).83-86. |
19. 于军辉, 宫珂, 吴文怡, 邓莹婵, 张能维, 关雷, 樊庆, 李雁*.改良教具在外科学总论实习课中的应用.医学研究杂志.2021.50(3).136-139. |
20. Ji ZH, Zhang Y, Li Y*.Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review.Gastrointest Oncol.2021.12 (Suppl 1).S70-S78.SCI |
21. Du XM, Wei YP, Gao Y, Li Z, Zhang JM, Chang H, Li Y*.Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: a case report.Medicine (Baltimore).2021.100 (12).e25264.SCI |
22. Yang ZR, Chen ZG, Ji ZH, Lin YL, Zhang J, Ma R, Li Z, Jiang X, Chen Q, Du XM, Li Y*.Establishment and histopathological study of patient-derived xenograft models and primary cell lines of epithelioid malignant peritoneal mesothelioma.Exp Anim.2021.70(2).225-235.SCI |
23. 闫国军, 刘刚, 姬忠贺, 杜雪梅, 李雁*.CRS+HIPEC 联合胸腔灌注+系统化疗治疗腹膜间皮瘤并胸腔转移 1 例及文献复习.首都医科大学学报.2021.42(3).480-484. |
24. 崔力方, 陈奕至, 昌红, 高颖, 李雁*.青年女性乳腺浸润性导管癌及其分子亚型的临床病理学特点.诊断病理学杂志.2021.28(7).562-566,571. |
25. Lin YL, Li Y*.The biological synthesis and the function of mucin 2 in pseudomyxoma peritonei.Cancer Manag Res.2021.13.7909-7917.SCI |
26. 安松林, 蔡建, 王辉, 李雁*.完全肿瘤细胞减灭术是改善结直肠癌腹膜转移患者预后的关键——评述PROPHYLOCHIP和PRODIGE7研究.中华胃肠外科杂志.2021.24(3).220-224. |
27. Li Y, Lin HR, Huang KS, Zhao JN.Efficacy of conversion surgery after neoadjuvant intraperitoneal-systemic chemotherapy in treating peritoneal metastasis of gastric cancer.J BUON.2021.26 (1).211-217.SCI |
28. Zhao J, Zhang YB, Yang XY, Wang ZJ, Song QK, Gong P, Zhao SH, Liu FR, Zhang ZN, Bai WP, Li Y*.Risk factors of pleural effusion after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in late-stage and recurrent ovarian cancer.Ann Palliat Med.2021.10 (1).385-391.SCI |
29. Lin YL, Xu DZ, Li XB, Yan FC, Xu HB, Peng ZH, Li Y*.Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines.J Orphanet J Rare Dis.2021.16(1).85.SCI |
30. Yu JH, Feng Y, Li XB, Zhang CY, Shi F, An SL, Liu G, Zhang YB, Zhang K, Ji ZH, Li B, Yan GJ, Li YP, Li Y*.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis from breast cancer: a preliminary report of 4 cases.Gland Surg.2021.10 (4).1315-1324.SCI |
31. Sun PP, Ma R, Liu G, wang LL, Chang H, Li Y*.Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases.Ann Transl Med.2021.9(7).574.SCI |
32. Ji ZH, Yu Y, Liu G, An SL, Zhang YB, Li B, Li XB, Yan GJ, Li Y*.Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: a single-center retrospective analysis of 125 patients.Eur J Surg Oncol.2021.47 (6).1411-1419.SCI |
33. Wang LL, Ji ZH, Gao Y, Chang H, Sun PP, Li Y*.Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review.World J Surg Oncol.2021.19 (1).193.SCI |
34. Yu JH, Lin YL, Ji ZH, Chen YZ, Li Y*.Malignant struma ovarii: a case report and literature review.Eur J Gynaecol Oncol.2021.42(2).244-249.SCI |
35. Ma R, Lin YL, Li XB, Yan FC, Xu HB, Peng Z, Li Y*.Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study.Diagn Pathol.2021.16(1).116.SCI |
36. Zhang J, Li XB, Ji ZH, Ma R, Bai WP, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival with acceptable safety for advanced ovarian cancer: a clinical study of 100 patients.Biomed Res Int.2021.2021.5533134.SCI |
37. 中国抗癌协会腹膜肿瘤专业委员会, 中国抗癌协会肿瘤热疗专业委员会, 北京癌症防治学会肿瘤热疗专业委员会, 李雁*.弥漫性恶性腹膜间皮瘤诊治中国专家共识.中华医学杂志.2021.101(36).2839-2849. |
38. 马茹, 姬忠贺, 张颖, 李雁*.胃肠道癌腹膜转移的核心病理机制.中华胃肠外科杂志.2021.24(3).199-204. |
39. Yan FC, Zhou Q, Lin YL, Yu CK, Chang H, Li Y*.Clinicopathological analysis of primary carcinoid tumour of the ovary arising in mature cystic teratomas.J Int Med Res.2021.49(8).3000605211034666.SCI |
40. Sun PP, Du XM, Gao Y, Zhao HY, Wang LL, Zhang Y, Li Y*.Clinicopathologic features of retroperitoneal malignant solitary fibrous tumors.Crit Rev Eukaryot Gene Expr.2021.31(4).21-33.SCI |
41. 姬忠贺, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜转移的现状与前景.外科理论与实践.2021.26(1).11-16. |
42. 杜雪梅, 昌红, 李雁*.恶性腹膜间皮瘤临床病理进展.临床与实验病理学杂志.2021.37(4).441-445. |
43. 刘玉翔, 叶昱坪, 孙磊, 王旺河, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜癌62例分析.临床医学.2021. 41(6).11-14. |
44. 于洋, 李鑫宝, 林育林, 马茹, 姬忠贺, 张彦斌, 安松林, 刘刚, 杨肖军, 李雁*.肿瘤细胞减灭术联合腹腔热灌注化疗治疗腹膜癌1384例疗效分析.中华胃肠外科杂志.2021.24(3).230-239. |
45. 徐大钊, 林育林, 李雁*.鸟苷酸结合蛋白α亚基变异与腹膜假黏液瘤关系的研究进展.中国肿瘤临床.2021.48(8).415-419. |
46. 张凯, 刘刚, 姬忠贺, 李鑫宝, 李雁*.CRS+HIPEC治疗复杂腹膜后侵袭性纤维瘤病长期无病生存1例.中国肿瘤临床.2021.48(2).105-106. |
47. 王玲玲, 姬忠贺, 高颖, 昌红, 周全, 孙萍萍, 张颖, 李雁*.促结缔组织增生性小圆细胞肿瘤的临床病理特征分析.中国肿瘤临床.2020.47(02).72-76.核心期刊 |
48. 杨智冉, 陈志高, 林育林, 姬忠贺, 陈谦, 李雁*.阿帕替尼抑制恶性腹膜间皮瘤细胞生物学研究.中华实验外科杂志.2020.37(12).2244-2246. |
49. 姬忠贺, 刘刚, 安松林, 张彦斌, 李兵, 于洋, 李鑫宝, 闫国军, 李雁*.完全肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜转移的病例筛选策略.中国肿瘤临床.2020.47(03).128-134.核心期刊 |
50. 姬忠贺, 李鑫宝, 于洋, 闫风彩, 李雁*.开拓临床肿瘤实践前沿创建腹膜肿瘤学科.中国肿瘤临床.2020.47(03).110-113.核心期刊 |
51. 闫风彩, 周全, 昌红, 李雁*.病理科轮转医师规范化培训的教学实践.诊断病理学杂志.2020.27(09).688-689.核心期刊 |
52. Paul H. Sugarbaker, 杨智冉, 李雁*.国际腹膜癌治疗指南: 肿瘤细胞减灭术加腹腔化疗临床路径.中国肿瘤临床.2020.47(11).541-551.核心期刊 |
53. 李鑫宝, 马茹, 姬忠贺, 林育林, 张珏, 杨智冉, 李雁*.肿瘤细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤的围手术期安全性研究.中华肿瘤杂志.2020.42(05).419-424.核心期刊 |
54. Lin YL, Li Y*.Study on the hepatocellular carcinoma model with metastasis.Genes & Diseases.2020.7(3).336-350.SCI |
55. Lin YL, Ma R, Li Y*.The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.J Cancer Res Clin Oncol.2020.146.2179-2188.SCI |
56. Yan GJ, Ji ZH, Liu G, Li Y*.CRS+ HIPEC combined with IP + IV chemotherapy for gastric signet-ring cell carcinoma: case report of long-term survival.Medicine (Baltimore).2020.99(41).1-6.SCI |
57. Yan FC, Shi F, Li XB, Yu Ck, Lin YL, Li Y*.Clinicopathological characteristics of pseudomyxoma peritonei originated from ovaries.Cancer Manag Res.2020.12.7569-7578.SCI |
58. 杨智冉, 林育林, 张珏, 马茹, 李曌, 蒋茜, 赵洪禹, 杜雪梅, 李雁*.恶性腹膜间皮瘤裸小鼠原位模型的建立及其生物学性状鉴定.中华病理学杂志.2020.49(02).162-167.核心期刊 |
59. 王玲玲, 马茹, 昌红, 高颖, 李雁*.肾上腺嗜铬细胞瘤的临床病理特征分析.临床肿瘤学杂志.2020.25(03).257-260.核心期刊 |
60. 马茹, 闫风彩, 李鑫宝, 林育林, 李雁*.肿瘤组织病理图像定量分析在腹膜假黏液瘤中的研究进展.医学综述.2020.26(23).4643-4649. |
61. 萍萍, 赵洪禹, 王玲玲, 张颖, 杜雪梅, 闫风彩, 李雁*.腹膜后恶性孤立性纤维性肿瘤的临床病理分析.临床肿瘤学杂志.2020.25(01).54-58.核心期刊 |
62. 张珏, 李鑫宝, 姬忠贺, 马茹, 白文佩, 李雁*.肿瘤细胞减灭术联合腹腔热灌注化疗治疗晚期卵巢癌效果观察.肿瘤研究与临床.2020.32(08).574-578.核心期刊 |
63. 马茹, 李鑫宝, 闫风彩, 林育林, 李雁*.肿瘤间质比评估阑尾来源腹膜假黏液瘤的临床价值.北京大学学报(医学版).2020.52(02).240-246.核心期刊 |
64. Lin YL, Zhang J, Yan FC, Jiang X, Ma R, Yang ZR, Xu HB, Peng Z, Chen Q, Li Y*.Establishment of ptient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil.Cancer Medicine.2020.9(3).1104-1114.SCI |
65. Yan FC,Lin YL, Zhou Q, Chang H, Li Y*.Pathological Prognostic Factors of Pseudomyxoma Peritonei:Comprehensive Clinicopathological Analysis of 155 Cases.Hum Pathol.2020.97.9-18.SCI |
66. Li XB, Ma R, Ji ZH, Lin YL, Zhang J, Yang ZR, Chen LF, Yan FC, Li Y*.Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.Eur J Surg Oncol.2020.46(4 Pt A).600-606.SCI |
67. 张珏,梅列军, 汪付兵, 李雁*.卵巢癌肿瘤细胞减灭术加腹腔热灌注化疗疗远期无瘤生存一例报告并文献复习.中华肿瘤防治杂志.2019.26(20).1574-1578.核心期刊 |
68. 张珏, 李鑫宝, 姬忠贺, 马茹, 李雁*.倾向性评分匹配评估肿瘤细胞减灭术联合腹腔热灌注化疗治疗晚期卵巢癌的疗效.中国肿瘤临床.2019.46(19).994-998.核心期刊 |
69. 李雁*, 许洪斌, 彭正, 崔书中, 吴畏, 梁寒, 朱正纲, 陆维祺, 李子禹, 徐惠绵, 刘骞, 赵赟博, 梁斌, 丁克峰, 吴玉梅, 张震宇, 杨国梁, 杨肖军, 周全, 卢一艳, 魏少忠.肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜假黏液瘤专家共识.中华医学杂志.2019.99(20).1527-1535.核心期刊 |
70. 李鑫宝, 姬忠贺, 林育林, 李雁*.细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤的研究进展.医学综述.2019.25(5).915-921. |
71. 姬忠贺, 李雁*.第十一届国际腹膜癌大会简况与思考.中华医学杂志.2019.99(2).158-160.核心期刊 |
72. 姬忠贺, 于洋, 刘刚, 张彦斌, 李兵, 安松林, 李鑫宝, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜转移的预后列线图构建与验证.中华普通外科杂志.2019.34(10).833-836. |
73. 李鑫宝, 姬忠贺, 于洋, 张彦斌, 刘刚, 李兵, 张凯, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗阑尾腺癌腹膜癌的临床研究.实用肿瘤杂志.2019.34(01).66-71.核心期刊 |
74. Ji ZH, An SL, Li XB, Liu G, Li Y*.Long-term progression-free survival of hepatocellular carcinoma with synchronous diffuse peritoneal metastasis treated by CRS+HIPEC: A case report and literature review.Medicine.2019.98(8).e14628.SCI |
75. 姬忠贺, 李雁*.胃癌腹膜转移的研究进展.中华普通外科杂志.2019.34(10).825-827. |
76. 李鑫宝,姬忠贺,张彦斌,刘刚,李兵,安松林,于洋,张凯,林育林,李雁*.肿瘤细胞减灭术加腹腔热灌注化疗围手术期静脉血栓栓塞症的危险因素及防治技术.肿瘤防治研究.2019.46(2).121-126. |
77. Li XB, Peng KW, Ji ZH, Yu Y, Liu G, Li Y*.Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program.Clin Appl Thromb Hemost.2019.25.1076029619890415.SCI |
78. 闫风彩, 李鑫宝, 林育林, 余春开, 周全, 李雁*.卵巢来源腹膜假黏液瘤临床病理分析.中国肿瘤临床.2019.46(17).887-890.核心期刊 |
79. 闫风彩, 林育林, 赵洪禹, 周全, 昌红, 李雁*.腹膜假黏液瘤155例病理预后因素分析.中华病理学杂志.2019.48(7).543-549.核心期刊 |
80. 林育林, 张珏, 杨智冉, 李鑫宝, 姬忠贺, 许洪斌, 彭正, 李雁*.腹膜假黏液瘤人源异种移植模型的研究进展.医学综述.2019.25(14).2842-2849. |
81. 姬忠贺, 李雁*.胃癌腹膜转移的研究进展.中华普通外科杂志.2019.34(10).825-827. |
82. 杜雪梅, 李鑫宝, 马玲, 高颖, 孙萍萍, 李雁*.腹膜恶性间皮瘤中肿瘤浸润淋巴细胞和Ki-67表达与临床病理特征及预后的关系.临床与实验病理学杂志.2019.35(8).920-928.核心期刊 |
83. Li XB, Ji ZH, Li Y*.Peritoneal Carcinomatosis Diagnosis and Treatment in China: Focusing on Training and Collaboration.Indian Journal of Surgical Oncology.2019.10(Suppl 1).12-18. |
84. 林育林, 张珏, 闫风彩, 蒋茜, 马茹, 杨智冉, 李雁*.腹腔注射5-氟尿嘧啶治疗腹膜假黏液瘤的人源异种移植模型.中华实验外科杂志.2019.36(10).1798-1801.核心期刊 |
85. 林育林, 张珏, 杨智冉, 李鑫宝, 姬忠贺, 许洪斌, 闫风彩, 周全, 彭正, 李雁*.腹膜高级别黏液癌伴印戒细胞裸小鼠模型的建立及生物学功能鉴定.中华肿瘤杂志.2019.41(12).923-931.核心期刊 |
86. 姬忠贺, 李鑫宝, 刘刚, 于洋, 林育林, 张彦斌, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗110例胃癌腹膜癌临床分析.中华医学杂志.2018.98(38).3097-3083.核心期刊 |
87. 李鑫宝, 林育林, 姬忠贺, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜假黏液瘤182例分析. 中国肿瘤临床.2018.45 (18).943-949.核心期刊 |
88. 刘刚, 李鑫宝, 姬忠贺, 刘勇, 张敏, 王勇, 李雁*.D-二聚体联合凝血酶时间检查对腹膜癌患者下肢深静脉血栓排除的诊断价值.中国普通外科杂志.2018.27(06).740-746.核心期刊 |
89. 林育林, 姬忠贺, 李鑫宝, 赵东兵, 李子禹, 李雁*. 临床医师综合考评方法探析.中华医学教育杂志.2018.38(5).782-786.核心期刊 |
90. 孙建华,姬忠贺,李雁*.细胞减灭术加腹腔热灌注化疗治疗复发性卵巢癌.肿瘤学杂志.2018.24(3).240-246.核心期刊 |
91. Zhang J, Yuan JP, Wang Q, Shao LH, Liu SP, Firestone RA, Hong YP, Li JG, Xin YC, Li Y* .Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer.Oncotarget..2018.(9)2.1957-1968. |
92. 姬忠贺, 刘洋, Yonemura Y, 李雁*.5-氨基酮戊酸光动力学诊断腹膜转移癌的研究进展. .首都医科大学学报.2018.39(3).469-475.核心期刊 |
93. Peng CW, Liu JY, Yang GF, Li Y*.The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system.J Gastroenterol.2018. 53(5). 606-617.SCI |
94. Yonemura Y*, Ishibashi H, Hirano M, Mizumoto A, Takeshita K, Noguchi K, Takao N, Ichinose M, Liu Y, Li Y.Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal/systemic chemotherapy on peritoneal metastases from gastric cancer..Annals of Surgical Oncology.2017.24(2).478–485.SCI |
95. Fang M, Chen M, Liu LL, Li Y*.Applications of quantum dots in cancer detection and diagnosis: a review..J Biomed Nanotechnol..2017.13(1).1-16.SCI |
96. 张彦斌, 姬忠贺, 刘刚, 于洋, 李兵, 李鑫宝, 王岩, 张展志, 李雁*.双套管持续冲洗负压引流治疗腹膜癌术后胃肠瘘[J].中华普通外科杂志.2017.32(6).505-507.核心期刊 |
97. Wu H, Liu SP, Gong J, Liu JY, Zhang Q, Leng XH, Zhang N, Li Y*..VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction..Cancer Lett..2017.393.22-32.SCI |
98. Huang CQ, Min Y, Wang SY, Yang XJ, Liu Y, Xiong B, Yonemura Y, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence..Oncotarget.2017.8(33).55657-55683.SCI |
99. Liu JY, Peng CW, Yang GF, Hu WQ, Yang XJ, Xiong B, Li Y*.Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer..Oncotarget.2017.8(54).92757-92769.SCI |
100. Peng CW, Liu JY, Yang GF, Li Y*.The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system..J Gastroenterol..2017.(10).DOI: 10.1007/s00535-017-1379-1..SCI |
101. Ji ZH, Peng KW, Yu Y, Li XB, Yonemura Y, Liu Y, Sugarbaker PH, Li Y*.Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases..Int J Hyperthermia..2017.33(5).562-570.SCI |
102. Geng XF, Fang M, Liu SP, Li Y*.Quantum dot-based molecular imaging of cancer cell growth using a clone formation assasy..Molecular Medicine Reports.2016.4(14).3007-3012.SCI |
103. Yan Li*, Yun-Feng Zhou, Han Liang, Hua-Qing Wang, Ji-Hui Hao, Zheng-Gang Zhu, De-Seng Wan, Lun-Xiu Qin, Shu-Zhong Cui, Jia-Fu Ji, Hui-Mian Xu, Shao-Zhong Wei, Hong-Bin Xu, Tao Suo, Shu-Jun Yang, Cong-Hua Xie, Xiao-Jun Yang, Guo-Liang Yang.Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. .World J Gastroenterol.2016.22(30).6906-6916.SCI |
104. Yonemura Y*, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem H..A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent..European Journal of Surgical Oncology .2016.42(8).1123–1131.SCI |
105. Wu HT, Peng KW, Ji ZH, Sun JH, Zhang Q, Yang XJ, Huang CQ, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: results from a Chinese center..European Journal of Surgical Oncology .2016.7(42).1024–1034.SCI |
106. Zhonghe Ji, Jianhua Sun, Haitao Wu, Qian Zhang, Kaiwen Peng, Yan Li*.Assessment of Hyperthermic Inreaperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells..Translational Oncology.2016.9(1).18-24.SCI |
107. 6. Jianhua Sun, Zhonghe Ji, Yang Yu, Haitao Wu, Chaoqun Huang, Qian Zhang, Xiaojun Yang, Yutaka Yonemura, Yan Li*.Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent EpithelialOvarian Cancer: Results from a Retrospective Study on Prospectively Established Database..Translational Oncology.2016.9(2).130-137.SCI |
108. Jianhua Sun, Zhonghe Ji, Kaiwen Peng, Haitao Wu, Qian Zhang, Yukata Yonemura, Yan Li*.Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study..International Journal of Hyperthermia.2016.16.1-9.SCI |
109. Linwei Wang, Aiping Ou, Wenlou Liu, Jiamei Chen, Jingping Yuan, Han Wu, Yan Li*, Juan Liu..Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement..Scientific Reports.2016.6.20564.SCI |
110. Jiuyang Liu, Xiafei Geng, Yan Li*.Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis..Tumor biology.2016.37(5).5715-26.SCI |
111. Zeng WJ, Peng CW, Yuan JP, Cui R, Li Y*.Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification..Int J Nanomedicine.2015.10.1759-68.SCI |
112. Sun J, Chen C, Wei W, Zheng H, Yuan J, Tu YI, Yao F, Wang L, Yao X, Li J, Li Y*, Sun S..Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study .Oncol Lett.2015.10(3).1741-1748.SCI |
113. Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y*, Yang G.Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.Hum Pathol.2015.46(12).1872-80.SCI |
114. Wang XY, Pei Y, Xie M, Jin ZH, Xiao YS, Wang Y, Zhang LN, Li Y, Huang WH.Artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells.Lab Chip.2015.15(4).1178-87.SCI |
115. Qu AP, Chen JM, Wang LW, Yuan JP, Yang F, Xiang QM, Maskey N, Yang GF, Liu J, Li Y* .Segmentation of Hematoxylin-Eosin stained breast cancer histopathological images based on pixel-wise SVW classifier.Science China Information Sciences.2015.58(9).092105:1-092105:13..SCI |
116. Wei YH, Zhou FX, Li Y, Zhou YF, Anish K, Xu LY, Liao MY.Extrapleural locating method in computed tomography-guided needle biopsies of 1,106 lung lesions .Exp Ther Med.2015.10(5).1707-1719.SCI |
117. Hu M, Li K, Maskey N, Xu Z, Peng C, Tian S, Li Y, Yang G.15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.International Journal of Clinical and Experimental Pathology.2015.8(6).6910-6918.SCI |
118. Xu H, Chen C, He Y, Tang HW, Zhang ZL, Li Y*, Pang DW.Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging.J Fluoresc.2015.25(2).397-402.SCI |
119. Liu WL, Wang LW, Chen JM, Yuan JP, Xiang QM, Yang GF, Qu AP, Liu J, Li Y*.Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study.Tumour Biol.2015.37(4).5013-24.SCI |
120. Tan Y, Li Y*.HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1.Biochem Biophys Res Commun.2015.466(3).592-598.SCI |
121. Chen JM, Qu AP, Wang LW, Yuan JP, Yang F, Xiang QM, Maskey N, Yang GF, Liu J, Li Y*.New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images.Scientific Reports.2015.29(5).10690.SCI |
122. Zeng WJ, Peng CW, Yuan JP, Cui R, Li Y#.Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification.International Journal of Nanomedicine.2015.10.1759-1768.SCI |
123. Xiang QM, Wang LW, Yuan JP, Chen JM, Yang F, Li Y*.Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer.experimental and molecular pathology.2015.99(1).133-138.SCI |
124. Yuan JP, Wang LW, Qu AP, Chen JM, Xiang QM, Chen C, Sun SR, Pang DW, Liu J, Li Y*.Quantum dots-based quantitative and in situ multiple imaging on Ki67 and cytokeratin to improve ki67 assessment in breast cancer.PLoS One.2015.10(4).0122734.SCI |
125. Wang LW, Peng CW, Chen C, Li Y*.Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives.Breast Cancer Res Treat.2015.151(1).7-17.SCI |
126. Hu WQ, Wang LW, Yuan JP, Yan SG, Li JD, Zhao HL, Peng CW, Yang GF, Li Y*.High Expression of Transform Growth Factor Beta 1 in Gastric Cancer Confers Worse OutcomeResults of a Cohort Study on 184 Patients.Hepatogastroenterology.2014.61(129).245-50.SCI |
127. Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD1, Zhao HL, Peng CW, Yang GF, Li Y*.Long term follow up and retrospective study on 533 gastric cancer cases.BMC Surg.2014.14(29).2-8.SCI |
128. Wang LW, Yang GF, Chen JM, Yang F, Yuan JP, Sun SR, Chen C, Hu MB, Li Y*.A Clinical Database of Breast Cancer Patients Reveals Distinctive Clinico-pathological Characteristics: a Study From Central China.Asian Pacific Journal of Cancer Prevention.2014.15(4).1621-1626.SCI |
129. Huang CQ, Yang XJ, Yu Y, Wu HT, Liu Y, Yonemura Y, Li Y*.Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center.plos one.2014.9(9).108509.SCI |
130. Fang M, Yuan J, Peng C, Li Y*.Collagen as a double-edged sword in tumor progression.Tumor Biol..2013.35(4).2871-82.SCI |
131. Huang CQ, Feng JP, Yang XJ, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center..Journal of Surgical Oncology.2013.109(7).23545.SCI |
132. Zhong YJ, Shao LH, Li Y*.Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy.INTERNATIONAL JOURNAL OF ONCOLOGY.2013.42(2).373-383.SCI |
133. Fang M, Peng CW, Yuan JP, Zhang ZL, Pang DW, Li Y*.Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma.Future Oncol.2013.9(7).1029–1037.SCI |
134. Peng CW, Wang LW, Zeng WJ, Yang XJ, Li Y*.Evaluation of the staging systems for gastric cancer..Journal of Surgical Oncology.2013.108(2).93-105.SCI |
135. Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD, Zhao HL, Peng CW, Yang GF, Li Y*.Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases.ONCOLOGY LETTERS.2013.6(6).1693-1700.SCI |
136. Fang M, Yuan JP, Peng CW, Pang DW, Li Y*.Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion.Biomaterials.2013.34(34).8708e8717.SCI |